Leyden Laboratories B.V. has unveiled promising results from its study on intranasal antibody therapy, CR9114, which demonstrates broad-spectrum protection against influenza viruses, including A, B, C, and D strains. The research highlights the benefits of delivering antibodies directly to the nasal mucosa, offering a novel, low-dose approach to combating respiratory infections with a unique Fc-independent mechanism of action.

Secure Your Spot in the Dutch Innovator Village at HLTH Europe 2025! Are you ready to present your health tech innovation to the world at HLTH...

Researchers at Leiden University’s Institute of Biology have discovered that zebrafish display genetically inherited personality traits, categorized as proactive or reactive, which could aid in developing treatments for mental health conditions like ADHD and depression. This groundbreaking study highlights the genetic similarities between zebrafish and humans, offering new insights into how these traits could be leveraged for more effective drug testing.

The Leiden Bio Science Park promotes innovation and collaboration through employee well-being, workplace dynamics, and international talent...

European Commission Delegation Visits Johnson & Johnson at Leiden Bio Science Park This month, Leiden Bio Science Park had the honour of...

The Life Sciences Café on March 20th marked the official launch of the Deelakkoord Human Capital Agenda Leiden Bio Science Park 2024-2027. This...

Health Holland has officially launched the Industrial PhD Call 2025, inviting companies and research organizations to collaborate in advancing the...

Last week, science students in Leiden took a big step toward their future at Bètabanenmarkt — and we were proud to be part of it! Participants had...

7 March 2025 to 8 March 2026 'Unseen' reveals how, for centuries, medical science has taken the male body as the norm, often overlooking women and...